Summary
This narrative review by Djuricic and Calder, published in Nutrients in 2021, synthesises updated evidence on the beneficial roles of both omega-6 and omega-3 polyunsaturated fatty acids in human health. The paper likely covers mechanisms of action, recommended intakes, and evidence from clinical and observational research across a range of health conditions including cardiovascular disease, inflammation, and brain health. As a 2021 update, it incorporates more recent trial data and reflects current understanding of the balance and individual roles of these fatty acid classes.
UK applicability
The findings are broadly applicable to UK dietary guidelines and public health policy, particularly in the context of NHS recommendations on oily fish consumption and omega-3 intake. UK dietary surveys consistently show insufficient long-chain omega-3 intake in the population, making this review relevant to UK nutrition strategy.
Key measures
Cardiovascular disease risk markers; inflammatory biomarkers; neurological outcomes; metabolic health indicators; dietary intake levels of EPA, DHA, ALA, and linoleic acid
Outcomes reported
The paper reviewed evidence on the health effects of omega-6 and omega-3 polyunsaturated fatty acids (PUFAs), including their roles in cardiovascular, metabolic, inflammatory, and neurological outcomes. It likely assessed updated evidence from clinical trials and epidemiological studies available up to 2021.
Topic tags
Dig deeper with Pulse AI.
Pulse AI has read the whole catalogue. Ask about this record, its theme, or how the findings apply to UK farming and policy — every answer cites the underlying studies.